CLOSE

Download our app Kalpataru Share trading from Google/App Store and transfer fund instantly.

SHREE GANESH REMEDIES LTD.

NSE : NABSE : 540737ISIN CODE : INE414Y01015Industry : Pharmaceuticals & DrugsHouse : Private
BSE794.703.25 (+0.41 %)
PREV CLOSE () 791.45
OPEN PRICE () 792.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 4121
TODAY'S LOW / HIGH ()773.20 815.50
52 WK LOW / HIGH () 475.55950.05
NSE
This Company is not listed in NSE
Select year
(Rs.in Million)
Particulars
Mar 2024
Mar 2020
Mar 2019
Profit Before Tax
381.60
135.90
86.66
Adjustment
58.93
-36.64
-3.49
Changes In working Capital
-54.68
-53.38
-135.34
Cash Flow after changes in Working Capital
385.86
45.87
-52.16
Cash Flow from Operating Activities
304.48
45.87
-52.16
Cash Flow from Investing Activities
-330.09
-29.10
-0.76
Cash Flow from Financing Activities
98.41
-4.76
-1.77
Net Cash Inflow / Outflow
72.80
12.02
-54.69
Opening Cash & Cash Equivalents
86.57
11.27
64.63
Cash & Cash Equivalent on Amalgamation / Take over / Merger
NA
NA
NA
Cash & Cash Equivalent of Subsidiaries under liquidations
NA
NA
NA
Translation adjustment on reserves / op cash balalces frgn subsidiaries
NA
NA
NA
Effect of Foreign Exchange Fluctuations
-0.83
NA
NA
Closing Cash & Cash Equivalent
158.54
23.29
9.94

registration nos:

Kalpataru Multiplier Ltd.: SEBI Regn. No. INZ000259437

Registered address: Kalpataru House, 18 Itwara, Bhopal (MP) – 462001

Member Member ID
Bombay Stock Exchange Ltd.(BSE) 3016
National Stock Exchange Ltd. 11152
Multi Commodity Exchange(MCX) 16020

Depository Participant of CDSL DP-ID 12031600

(SEBI Regn No. IN-DP-CDSL-221-2003)

In absence of response/ complaint not addressed to your satisfaction, you may lodge a complaint and reach out to us on:

SMART ODR PORTAL @ https://smartodr.in/login

Copyright © 2016 Kalparatu Multiplier Ltd.
Designed ,Developed & Content Powered by  Accord Fintech Pvt. Ltd.
SENSEX79389.06-553.12 (-0.69%)
NIFTY24205.35-135.50 (-0.56%)
Dow Jones 42141.54-91.51 (-0.22%)
Nasdaq 18607.93-104.82 (-0.56%)
CLOSE Disclosure
CLOSE

INFORMATION UNDER THE HEAD SHOULD BE ADDED AS FOLLOWS

  • Sharing of trading credentials - login id & password including OTP's.
  • Trading in leveraged products like options without proper understanding, which could lead to losses.
  • Writing / selling options or trading in option strategies based on tips, without basic knowledge & understanding of the product and its risks.
  • Dealing in unsolicited tips through Whatsapp, Telegram, YouTube, Facebook, SMS, Calls, etc.
  • Trading in "Options" based on recommendations from unauthorised / unregistered investment advisors and influencers.
CLOSE SEBI